Toronto, Ontario, Canada, October 22, 2026
Perimeter Medical Imaging AI, Inc., a commercial-stage medical technology company focused on cancer surgery, has announced that its Chief Executive Officer, Adrian Mendes, will present a company update at the Planet MicroCap Showcase in Toronto on October 28, 2026. The presentation will cover the company’s commercial strategy and anticipated milestones as it advances AI-enabled imaging technology for breast cancer surgery. The announcement highlights Perimeter’s efforts to expand awareness of its medical imaging portfolio among investors and other industry stakeholders. The company operates in the medical technology sector, developing high-resolution optical imaging systems designed to help physicians assess tissue during breast-conserving surgical procedures.
CEO to Discuss Commercial Strategy and Upcoming Milestones
Mendes is scheduled to present at 3:30 p.m. Eastern Time on October 28, 2026. The Planet MicroCap Showcase, organized in partnership with MicroCapClub, brings together publicly traded companies, investors, and analysts for presentations, individual meetings, and discussions about business developments. Perimeter’s presentation is expected to provide an update on its commercial priorities and upcoming milestones. The company also plans to make a live and archived webcast available through its investor relations website, allowing interested audiences to access the presentation remotely. The event provides an opportunity for Perimeter to communicate its business strategy as it develops and commercializes imaging technologies intended to address unmet needs in cancer surgery. The company’s participation is an investor-relations activity; the announcement does not disclose new clinical trial results, regulatory clearances, or product performance data.
AI-Enabled Imaging for Breast Cancer Surgery
Based in Toronto, Canada, and Dallas, Texas, Perimeter Medical Imaging AI develops ultra-high-resolution optical coherence tomography (OCT) systems intended to provide real-time visualization of excised tissue. Its technology is designed to support surgeons evaluating tissue margins during breast-conserving surgery. The company’s Claire OCT System combines three-dimensional imaging with an artificial intelligence-based computer-aided detection algorithm that identifies and marks areas suspicious for breast cancer in the images. The system is intended for use alongside physician interpretation and other standard methods for evaluating excised lumpectomy tissue in patients with a biopsy-confirmed breast cancer diagnosis. Perimeter emphasizes that the system is an adjunctive imaging tool. It is not intended to replace standard histopathology assessment or serve as a standalone diagnostic method. Physicians must interpret its findings within the appropriate clinical context and follow the device’s authorized indications and safety information.
Advertisement
Investor Engagement and Future Development
The Planet MicroCap Showcase will also offer opportunities for investors to meet company management in person at the Arcadian Loft in Toronto. Perimeter stated that one-on-one investor meetings at the event will be conducted in person, while its company presentation will be available through a live and archived webcast. For medical technology companies, investor engagement can help communicate commercial objectives, development priorities, and plans for bringing products to market. In Perimeter’s case, the broader strategy centers on advanced imaging tools designed to support cancer surgery and address clinical needs in tissue assessment. The company’s announcement does not guarantee future commercial outcomes or establish additional clinical benefits. Its future progress will depend on factors including product adoption, regulatory requirements, clinical and technical evidence, and execution of its business strategy. Perimeter’s participation in the showcase therefore represents an opportunity to share its current direction and planned milestones with the investment community. For the wider medtech sector, the company’s work illustrates the continuing development of AI-assisted imaging technologies for surgical applications, where computational image analysis is combined with clinician interpretation rather than replacing established diagnostic procedures.
Source: Perimeter Medical Imaging AI press release
